Found: 106
Select item for more details and to access through your institution.
Excessive MET signaling causes acquired resistance and addiction to MET inhibitors in the MKN45 gastric cancer cell line.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1158, doi. 10.1007/s10637-013-9959-2
- By:
- Publication type:
- Article
Mechanisms of acquired resistance to insulin-like growth factor 1 receptor inhibitor in MCF-7 breast cancer cell line.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 2, p. 293, doi. 10.1007/s10637-012-9855-1
- By:
- Publication type:
- Article
Phase I dose-escalating study of panobinostat (LBH589) Administered intravenously to Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 5, p. 1950, doi. 10.1007/s10637-011-9751-0
- By:
- Publication type:
- Article
Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1352, doi. 10.1007/s10637-011-9699-0
- By:
- Publication type:
- Article
Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 3, p. 1055, doi. 10.1007/s10637-011-9637-1
- By:
- Publication type:
- Article
FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Serious Long-Term Effects of Head and Neck Cancer from the Survivors' Point of View.
- Published in:
- Healthcare (2227-9032), 2023, v. 11, n. 6, p. 906, doi. 10.3390/healthcare11060906
- By:
- Publication type:
- Article
Prognostic value of ALDH2 polymorphism for patients with oropharyngeal cancer in a Japanese population.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0187992
- By:
- Publication type:
- Article
Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE)
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11503-z
- By:
- Publication type:
- Article
Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells.
- Published in:
- Journal of Cancer Research & Therapeutics, 2021, v. 17, n. 4, p. 1093, doi. 10.4103/jcrt.JCRT_1222_20
- By:
- Publication type:
- Article
Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination.
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060965
- By:
- Publication type:
- Article
Exploratory Analysis to Predict Optimal Tumor Burden for Starting Lenvatinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.638123
- By:
- Publication type:
- Article
Severe and delayed-onset acneiform eruptions as an adverse reaction to regorafenib.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Mediastinal Germ Cell Tumor Exhibiting a Discrepancy between Tumor Markers and Imaging: A Case Study.
- Published in:
- Case Reports in Oncology, 2015, v. 8, n. 2, p. 323, doi. 10.1159/000438697
- By:
- Publication type:
- Article
Device-related Mycobacterium mageritense Infection in a Patient Treated with Nivolumab for Metastatic Breast Cancer.
- Published in:
- Internal Medicine, 2021, v. 60, n. 21, p. 3485, doi. 10.2169/internalmedicine.6550-20
- By:
- Publication type:
- Article
Roles of skull base surgery and particle radiotherapy for orbital malignant tumors involving the skull base.
- Published in:
- Laryngoscope Investigative Otolaryngology, 2021, v. 6, n. 6, p. 1347, doi. 10.1002/lio2.687
- By:
- Publication type:
- Article
Correction to: Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan.
- Published in:
- Advances in Therapy, 2020, v. 37, n. 9, p. 3850, doi. 10.1007/s12325-020-01433-8
- By:
- Publication type:
- Article
Expression of programmed death‐1 in sentinel lymph nodes of breast cancer.
- Published in:
- Journal of Surgical Oncology, 2018, v. 117, n. 6, p. 1131, doi. 10.1002/jso.24937
- By:
- Publication type:
- Article
A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 1, p. 161, doi. 10.1007/s10120-013-0247-9
- By:
- Publication type:
- Article
Lenvatinib for Anaplastic Thyrid Cancer.
- Published in:
- Frontiers in Oncology, 2017, v. 7, p. 1, doi. 10.3389/fonc.2017.00025
- By:
- Publication type:
- Article
Left atrial extension of metastatic lung tumor via pulmonary vein: report on the first case of Ewing sarcoma.
- Published in:
- Rare Tumors, 2010, v. 2, n. 3, p. 151, doi. 10.4081/rt.2010.e53
- By:
- Publication type:
- Article
Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 9, p. 1619, doi. 10.1007/s10147-021-01949-1
- By:
- Publication type:
- Article
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1).
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 233, doi. 10.1007/s10147-020-01831-6
- By:
- Publication type:
- Article
Role of intensive nutrition support and prophylactic percutaneous endoscopic gastrostomy during concomitant chemoradiotherapy for oropharyngeal cancer.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 6, p. 1023, doi. 10.1007/s10147-018-1328-x
- By:
- Publication type:
- Article
Analysis of B‐cell receptor repertoire to evaluate immunogenicity of monovalent Omicron XBB.1.5 mRNA vaccines.
- Published in:
- EJHaem, 2024, v. 5, n. 4, p. 661, doi. 10.1002/jha2.932
- By:
- Publication type:
- Article
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141.
- Published in:
- Oncologist, 2022, v. 27, n. 2, p. e194, doi. 10.1093/oncolo/oyab036
- By:
- Publication type:
- Article
Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti‐Epidermal Growth Factor Receptor‐Induced Acne‐Like Rash: A Randomized Left‐Right Comparative Evaluation (APPEARANCE).
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. 885, doi. 10.1634/theoncologist.2019-0156
- By:
- Publication type:
- Article
CheckMate 141: 1‐Year Update and Subgroup Analysis of Nivolumab as First‐Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 1079, doi. 10.1634/theoncologist.2017-0674
- By:
- Publication type:
- Article
Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1056, doi. 10.1634/theoncologist.2017-0015
- By:
- Publication type:
- Article
Metabolomics Evaluation of Serum Markers for Cachexia and Their Intra-Day Variation in Patients with Advanced Pancreatic Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113259
- By:
- Publication type:
- Article
Effects of Aprepitant on the Pharmacokinetics of Controlled-Release Oral Oxycodone in Cancer Patients.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104215
- By:
- Publication type:
- Article
Prognostic Value of FDG PET Imaging in Patients with Laryngeal Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0096999
- By:
- Publication type:
- Article
Impact of baseline tumor burden on overall survival in patients with radioiodine‐refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 12, p. 2281, doi. 10.1002/cncr.34181
- By:
- Publication type:
- Article
Response to mRNA SARS‐CoV‐2 vaccination evaluated by B‐cell receptor repertoire after tixagevimab/cilgavimab administration.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 3, p. 504, doi. 10.1111/bjh.18932
- By:
- Publication type:
- Article
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Nonplatinum-based chemotherapy with irinotecan plus docetaxel for advanced or metastatic olfactory neuroblastoma: a retrospective analysis of 12 cases.
- Published in:
- 2008
- By:
- Publication type:
- journal article
A phase I study of LCL161, a novel oral pan‐inhibitor of apoptosis protein (IAP) antagonist, in Japanese patients with advanced solid tumors.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 5, p. e427, doi. 10.1111/ajco.13744
- By:
- Publication type:
- Article
Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2010, doi. 10.1177/1078155218816768
- By:
- Publication type:
- Article
Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00086
- By:
- Publication type:
- Article
A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinoma of the Head and Neck (CSPOR HN01: ECRIPS Study).
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00006
- By:
- Publication type:
- Article
Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Adjuvant treatment for post-operative head and neck squamous cell carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 1, p. 2, doi. 10.1093/jjco/hyu195
- By:
- Publication type:
- Article
Randomized Phase II/III Trial of Post-operative Chemoradiotherapy Comparing 3-Weekly Cisplatin with Weekly Cisplatin in High-risk Patients with Squamous Cell Carcinoma of Head and Neck: Japan Clinical Oncology Group Study (JCOG1008).
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 8, p. 770
- By:
- Publication type:
- Article
Prediction of Glomerular Filtration Rate in Cancer Patients by an Equation for Japanese Estimated Glomerular Filtration Rate.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 3, p. 271, doi. 10.1093/jjco/hys235
- By:
- Publication type:
- Article
Phase II Feasibility Trial of Adjuvant Chemoradiotherapy with 3-weekly Cisplatin for Japanese Patients with Post-operative High-risk Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 10, p. 927, doi. 10.1093/jjco/hys128
- By:
- Publication type:
- Article
Phase II Trial of Concurrent Chemoradiotherapy with S-1 Plus Cisplatin in Patients with Unresectable Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Japan Clinical Oncology Group Study (JCOG0706).
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 7, p. 460, doi. 10.1093/jjco/hyp040
- By:
- Publication type:
- Article